XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating expenses        
General and administrative $ 1,353,069 $ 1,318,986 $ 4,772,382 $ 3,903,545
Research and development 6,203,753 1,966,230 14,131,007 6,172,192
License fees 25,000 133,333 58,333 408,333
Total operating expenses 7,581,822 3,418,549 18,961,722 10,484,070
Loss from operations (7,581,822) (3,418,549) (18,961,722) (10,484,070)
Other income (expense) (986) 25,471 2,454 86,703
Net loss (7,582,808) (3,393,078) (18,959,268) (10,397,367)
Deemed dividend from trigger of down round provision feature (6,863) 0 (6,863) (789,594)
Net loss to common shareholders (7,589,671) (3,393,078) (18,966,131) (11,186,961)
Foreign currency translation adjustments 672 (15,378) (10,182) (15,674)
Comprehensive loss $ (7,588,999) $ (3,408,456) $ (18,976,313) $ (11,202,635)
Loss per common share - basic and diluted (in usd per share) $ (0.24) $ (0.20) $ (0.69) $ (0.76)
Weighted average number of common shares outstanding:        
Basic and diluted (in shares) 31,588,152 16,683,411 27,381,508 14,756,213